Skip to main content

Table 2 Comparision between mucosal healing group (MH Group) and non-mucosal healing group (NMH Group) at the end of TAC

From: Relationship between mucosal healing by tacrolimus and relapse of refractory ulcerative colitis: a retrospective study

 

MH Group

n = 41

NMH Group

n = 14

p-value

TAC at the end of data

 CAI

2.8 (1–4)

2.7 (1–4)

0.741

 Hb (g/dl)

11.7 (9.6–15.6)

13.2 (11–15.8)

0.098

 Alb (g/dl)

3.8 (3–4.7)

3.8 (2.9–4.6)

0.703

 CRP (mg/dl)

0.12 (0.04–1.15)

0.15 (0.03–1.03)

0.665

 Mayo score

0.63 (0–1)

2.21 (2–3)

0.001

 UCEIS score

1.19 (0–4)

4.42 (4–5)

0.001

Total prednisolone dose during hospitalization (mg)

685 (330–1690)

755 (335–1322)

0.501

Duration of TAC (days)

297.6 (58–922)

136.9 (70–373)

0.014

Combined use of AZA (yes / no)

34/7

11/3

0.715

Steroid free rate at 24 weeks

n (%)

35 (85.3%)

7 (50%)

0.012

  1. Data are expressed as the mean ± standard deviation or the number of patients
  2. AZA azathioprine